Event Details

Meet Immatics in Boston and network with our colleagues, interact with key opinion leaders, ask questions and debate on burning topics in the field of cancer immunotherapy.
 

• Poster 713 - The PRAME opportunity - high peptide copy numbers, homogenous expression and high prevalence to address a broad patient population across different solid cancers with TCR-based therapeutics

• Poster 1319 - Next-generation TCR Bispecifics (TCER) targeting peptide-HLA antigens for the treatment of patients with solid tumors

More details on the presentations will follow. For more information on the event itself, please visit SITC 2022.

We are looking forward to meeting you!